top of page

PHARMACEUTICAL
CREATIVE

FIRST, LEARN THE RULES. THEN, RESPECTFULLY BREAK THEM.

you're browsing

Anchor 1

ALLERGAN HEALTHCARE

 

Moon Rabbit, 2021-2022

​

Allergan (now part of AbbVie) came to us to develop new assets and evolve their AOR-created DTC campaign Because You're Human (BYH.)

 

The Repatha brand team wanted to develop patient stories that would empathize with people struggling to reduce their LDLs through traditional means.

​

This work led to other opportunities for Moon Rabbit– patient stills, a competitive campaign, a new website, an HCP campaign, and a version of BYH patient stories for Spanish-speaking consumers.

Anchor 2

VERRICA PHARMACEUTICALS

 

Moon Rabbit, 2023

​

In 2023, Moon Rabbit pitched to be Verrica's AOR for the upcoming launch of Ycanth, a dermatology drug used to treat molluscum contagiosum, a predominantly childhood-impacting disease.​

​

Assets:

  • Ycanth Patient Education Brochure

  • Branded website

​

Ycanth.com

Anchor 3

OPIANT PHARMACEUTICALS

 

Moon Rabbit, 2021-2023

​

In 2021, Opiant awarded Moon Rabbit the launch work for their new opioid antagonist, OPVEE. I led and created a range of unbranded and branded creative assets for this brand.

​

Assets:

  • MOD video​

  • Interactive Sales Aid (1st 9 pages)

  • Branded website

​

OVPEE.com

Anchor 4
Anchor 5

NYU STUDENT HEALTH CENTER POST-APPT HANDOUTS

​

NYU Student Health Center, 2018-2020

​

Before 2018, all patient documents were created by individual providers, leading to a fractured brand and missed opportunities for student health at NYU.

​

After establishing an overall brand for student health, a consistent look and feel were applied to providers’ most popular patient handouts through the Point and Click system. The updated versions explain the diagnosis, next steps, and any medical concerns without jargon.

​

Assets:

  • Ophthalmology, Contact Lenses Handout

Anchor 6

IVERIC BIO

Moon Rabbit, 2022

​

We pitched Iveric Bio to be their AOR.

​

They asked us to create a function pre-launch DSA campaign towards HCPs and retina specialists that would increase their sense of urgency to diagnose, refer, and treat GA in a broader range of patients.

​

Assets:

  • Unbranded concepts